Sorrento Therapeutics, Inc. SRNE
$0.00
$0.00-50.00%
OTC PK
SRNE Rating
Reward
Risk
SRNE Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
SRNE Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
SRNE Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
SRNE Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
SRNE Valuation
Market Cap Rank
#19,277
Enterprise Value
--
Price/Sales (TTM)
Price/Book (Q)
SRNE Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
SRNE Corporate Info
Website
Phone Number
858 203 4100
Address
4955 Directors Place
San Diego, CA 92121
San Diego, CA 92121
Country
Year Founded
SRNE Filings
Filing Date
Monday, August 14, 2023
Period Date
Friday, June 30, 2023
Next Filing
(est)
SRNE Headlines
There are no news to display.